UNION, MO – SDIX™ (Nasdaq: SDIX), a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic, and food safety applications, today announced it has signed a distribution agreement with Romer Labs® Inc. for SDIX’s Genetically Modified Organisms (GMO) rapid testing products.

Under terms of the agreement, Romer Labs® will have exclusive global distribution rights outside of Brazil to distribute SDIX’s TraitChek® and SeedChek® GMO test strip products. TraitChek® and SeedChek® are easy to use, accurate, and affordable GMO detection systems for grain and seed. TraitChek® tests enable rapid testing of grains for GMO at elevators and terminals. Visual results can be seen in 3 to 5 minutes, thereby expediting grain processing. SeedChek® tests and ELISA plates are used to rapidly test seed lots for quality control requirements and leaf tissue in the field. Visual results for SeedChek® can be seen in 3 to 5 minutes.

Transgenic seed varieties are marketed alongside conventional seed varieties. As a result, testing methods to determine the presence or absence of genetic traits is critical. SDIX offers both test strip and microwell ELISA plate test formats to meet the grain and seed testing demands for breeders, as well as grain, seed, and feed producers and consumers.

Tim Lawruk, SDIX Food Safety Market Manager, said, “As a world leader in diagnostic solutions for the feed and grain safety market, Romer Labs® is an excellent partner for SDIX and this collaborative distribution agreement will quickly provide important benefits to both companies. Romer will have access to SDIX’s advanced portfolio of rapid GMO detection technologies and SDIX will have access to a significant new global customer base through Romer’s extensive worldwide sales and marketing organization. In addition, it will enable SDIX to focus more of its sales and marketing resources on driving its Food Safety activities.”

According to Michael Prinster, CEO of Romer Labs® Inc., “The cooperation between SDIX and Romer Labs will be beneficial for both sides. It will allow Romer Labs® to get one step closer to our vision of becoming the number one provider of diagnostic solutions at all stages of the agricultural, food, and feed industry supply chain by being able to offer a range of well established and received GMO tests, in addition to its range of test systems for mycotoxins, food allergens, and veterinary drug residues. It will also allow SDIX immediate access to a global distribution network in the area of food safety via Romer Labs® subsidiaries and distributors.”

Hannes Binder, CEO of Romer Labs® Division Holding GmbH. in Austria, said, “This agreement once more demonstrates Romer Labs® position as a leading provider of diagnostic solutions in the agriculture, food and feed industries. In addition, Romer’s established kit development and intensive research and development activities make it an attractive cooperation and distribution partner for complimentary products like those from SDIX.”

About Romer Labs®

Romer Labs®, founded in Washington, MO in the U.S. in 1982, is a leader in diagnostic solutions for food and feed safety. The company has facilities in Austria, Brazil, China, Singapore, United Kingdom, and the USA. Diagnostic solutions offered include test systems for mycotoxins, food allergens, veterinary drug residues, melamine, and GMO testing. In addition, Romer Labs® also offers laboratory services in North America, Europe, and Asia. Romer Labs® also develops, produces and markets a range of standards, reference materials, and calibrants needed for analysis. Romer Labs® has been a trusted partner for the agriculture, food, and feed industry worldwide for more than 28 years.

About SDIX

SDIX is a biotechnology company, expert at creating advantage by providing a broad range of quality, innovative, and effective immuno-solutions to the Pharmaceutical, Biotechnology, Diagnostics, and Food Safety markets. For nearly 20 years, SDIX has developed antibodies which advance its customers’ immuno-based work – reducing time, labor, and costs while increasing accuracy and reliability of results. SDIX offers a full suite of integrated immuno-solution capabilities including assay design, development, and production. In life science markets, SDIX capabilities are being used to help discover the mechanisms of disease, facilitate the development of new drugs, and provide mechanisms for rapid diagnosis.